Skip to main content
Signal8

Holtham Angela

SEC insider (Form 3/4/5 filer). CIK 0002102488. Director at ONCOLYTICS BIOTECH INC (ONCY). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 1, 2026. Located in SAN DIEGO, CA.

Companies Holtham Angela has filed insider reports for

  • ONCOLYTICS BIOTECH INC (ONCY): Director
Holtham Angela profile photo

Holtham Angela

CIK: 0002102488

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ONCOLYTICS BIOTECH INC logo
ONCY

ONCOLYTICS BIOTECH INC

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ONCOLYTICS BIOTECH INC logo
    ONCY

    ONCOLYTICS BIOTECH INC

    Jun 1, 2026
    Award

    Stock Option

    Direct
    30K shares-

1-1 of 1